Cargando…
Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer
BACKGROUND: Although adjuvant chemotherapy with S-1 after curative gastrectomy has been performed as a standard treatment for Stage II and III gastric cancer (GC) in Japan, patients with Stage III GC still have a high incidence of recurrence and a poor prognostic outcome. The aim of this study was t...
Autores principales: | Nishibeppu, Keiji, Komatsu, Shuhei, Ichikawa, Daisuke, Imamura, Taisuke, Kosuga, Toshiyuki, Okamoto, Kazuma, Konishi, Hirotaka, Shiozaki, Atsushi, Fujiwara, Hitoshi, Otsuji, Eigo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791734/ https://www.ncbi.nlm.nih.gov/pubmed/29382310 http://dx.doi.org/10.1186/s12885-018-4052-z |
Ejemplares similares
-
Low levels of tumour suppressor miR-655 in plasma contribute to lymphatic progression and poor outcomes in oesophageal squamous cell carcinoma
por: Kiuchi, Jun, et al.
Publicado: (2019) -
Low plasma levels of miR-101 are associated with tumor progression in gastric cancer
por: Imamura, Taisuke, et al.
Publicado: (2017) -
A shorter distal resection margin is a surrogate marker of nodal metastasis and poor prognosis in distal gastrectomy for advanced gastric cancer
por: Takashima, Yusuke, et al.
Publicado: (2023) -
Plasma microRNA profiles: identification of miR-1229-3p as a novel chemoresistant and prognostic biomarker in gastric cancer
por: Nishibeppu, Keiji, et al.
Publicado: (2020) -
Overexpression of CTEN relates to tumor malignant potential and poor outcomes of adenocarcinoma of the esophagogastric junction
por: Aratani, Kenichi, et al.
Publicado: (2017)